Cargando…
Genetic and pharmacological inhibition of inflammasomes reduces the survival of Mycobacterium tuberculosis strains in macrophages
Mycobacterium tuberculosis infection causes high rates of morbidity and mortality. Host-directed therapy may enhance the immune response, reduce tissue damage and shorten treatment duration. The inflammasome is integral to innate immune responses but over-activation has been described in tuberculosi...
Autores principales: | Subbarao, Sathyavani, Sanchez-Garrido, Julia, Krishnan, Nitya, Shenoy, Avinash R., Robertson, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048741/ https://www.ncbi.nlm.nih.gov/pubmed/32111888 http://dx.doi.org/10.1038/s41598-020-60560-y |
Ejemplares similares
-
Pathways of IL-1β secretion by macrophages infected with clinical Mycobacterium tuberculosis strains()
por: Krishnan, Nitya, et al.
Publicado: (2013) -
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages
por: van Doorn, Cassandra L. R., et al.
Publicado: (2021) -
Vying for the control of inflammasomes: The cytosolic frontier of enteric bacterial pathogen–host interactions
por: Sanchez‐Garrido, Julia, et al.
Publicado: (2020) -
Inflammasomes in Mycobacterium tuberculosis-Driven Immunity
por: Wawrocki, Sebastian, et al.
Publicado: (2017) -
The Mycobacterium tuberculosis β-oxidation genes echA5 and fadB3 are dispensable for growth in vitro and in vivo
por: Williams, Kerstin J., et al.
Publicado: (2011)